Abstract
MRI is one of the main pillars of oncologic imaging and plays a vital role in the care of patients with cancer. Due to intrinsic proprieties such as superior soft tissue contrast resolution, multiplanar capability, functional imaging ability, and lack of ionizing radiation, MRI has become indispensible in the management of oncologic diseases. As the technology advances, its role will continue to expand at virtually every stage of patient care. In this chapter, we review the essential features of MRI in oncologic imaging and discuss the clinical use of MRI in the diagnosis, staging, treatment, and surveillance of common oncologic diseases. We also discuss recent and forthcoming advances in oncologic MRI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tatli S, Morrison PR, Tuncali K, Silverman SG. Interventional MRI for oncologic applications. Tech Vasc Interv Radiol. 2007;10(2):159–70.
Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–84.
Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology. 1990;176(3):593–606.
Kanal E, Borgstede JP, Barkovich AJ, American College of Radiology, et al. American College of Radiology white paper on MR safety. AJR Am J Roentgenol. 2002;178(6):1335–47.
Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet. 2000;356(9234):1000–1.
Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17(9):2359–62.
Shellock FG, Spinazzi A. MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol. 2008;191(4):1129–39.
Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol. 2006;27:475–87.
Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics. 2000;20(6):1721–49.
Thurnher MM, Law M. Diffusion-weighted imaging, diffusion-tensor imaging, and fiber tractography of the spinal cord. Magn Reson Imaging Clin N Am. 2009;17(2):225–44.
Caldemeyer KS, Mathews VP, Righi PD, Smith RR. Imaging features and clinical significance of perineural spread or extension of head and neck tumors. Radiographics. 1998;18(1):97–110.
Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am. 2002;10(3):511–25.
Yeh ED. Breast magnetic resonance imaging: current clinical indications. Magn Reson Imaging Clin N Am. 2010;18(2):155–69.
Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–8.
American College of Radiology. http://www.acr.org/. Accessed 1 Dec 2010.
American Cancer Society, Cancer Facts & Figures 2010. http://www.cancer.org/acs. Accessed 1 Dec 2010.
Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229:526–33.
Godelman A, Haramati LB. MR imaging in diagnosis and staging of pulmonary carcinoma. Magn Reson Imaging Clin N Am. 2008;16(2):309–17.
Syed IS, Feng D, Harris SR, et al. MR imaging of cardiac masses. Magn Reson Imaging Clin N Am. 2008;16(2):137–64.
Hoffmann U, Globits S, Schima W, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol. 2003;92(7):890–5.
El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134(6):1752–63.
Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging. 2001;13(3):397–401.
Barish MA, Yucel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med. 1999;341(4):258–64.
Sahni VA, Mortele KJ. Magnetic resonance cholangiopancreatography: current use and future applications. Clin Gastroenterol Hepatol. 2008;6(9):967–77.
Federle M, Chezmar J, Rubin D, et al. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials. Efficacy of early imaging. J Magn Reson Imaging. 2000;12(5):689–701.
Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology. 1995;196(2):471–8.
Nakayama M, Yamashita Y, Mitsuzaki K, Yi T, Arakawa A, Katahira K, Nakayama Y, Takahashi M. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging. 2000;11(6):647–54.
Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, Peters PE. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol. 1997;7(2):275–80.
Runge VM. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr. 1998;22(4):643–50.
Ji H, Ros PR. Magnetic resonance imaging. Liver-specific contrast agents. Clin Liver Dis. 2002;6(1):73–90.
Sauer R, Fietkau R, Wittekind C, German Rectal Cancer Group, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis. 2003;5:406–15.
Tatli S, Mortele KJ, Breen EL, Bleday R, Silverman SG. Local staging of rectal cancer using combined pelvic phased-array and endorectal coil MRI. J Magn Reson Imaging. 2006;23(4):534–40.
Eisner BH, Kurtz MP, Harisinghani MG. Evolving role of magnetic resonance imaging in renal cancer imaging. J Endourol. 2010;24(5):707–11.
Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology. 2008;249(1):16–31.
Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin. 2010;60(4):244–72.
Silverman SG, Leyendecker JR, Amis Jr ES. What is the current role of CT urography and MR urography in the evaluation of the urinary tract? Radiology. 2009;250(2):309–23.
Setty BN, Holalkere NS, Sahani DV, Uppot RN, Harisinghani M, Blake MA. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol. 2007;36(2):83–96.
Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005;184(1):121–7.
Hussain HK, Korobkin M. MR imaging of the adrenal glands. Magn Reson Imaging Clin N Am. 2004;12(3):515–44.
Korobkin M. Overview of imaging/CT. Urol Radiol. 1989;4:221–6.
Mayo-Smith WW, Lee MJ, McNicholas MMJ, Hahn PF, Boland GW, Saini S. Characterization of masses (<5 cm) by use of chemical shift MR imaging Observer performance versus quantitative measure. Am J Roentgenol. 1995;165(1):91–5.
Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol. 1995;165(3):579–83.
Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal–pelvic phased-array coils. Radiology. 1994;193(3):703–9.
Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T, Ito H. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr. 2005;29(2):149–53.
Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection – a multireader study. Radiology. 2009;250(1):145–51.
Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology. 1997;203(3):645–52.
Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229(1):248–54.
Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366(9484):491–505.
Frei KA, Kinkel K, Bonél HM, Lu Y, Zaloudek C, Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology. 2000;216(2):444–9.
Hricak H, Gatsonis C, Chi DS, American College of Radiology Imaging Network 6651, Gynecologic Oncology Group 183, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol. 2005;23(36):9329–37.
Hricak H, Gatsonis C, Coakley FV, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation – ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007;245(2):491–8.
Rieber A, Nüssle K, Stöhr I, et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol. 2001;177(1):123–9.
Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging–multivariate analysis. Radiology. 2000;214(1):39–46.
Ma LD. Magnetic resonance imaging of musculoskeletal tumors: skeletal and soft tissue masses. Curr Probl Diagn Radiol. 1999;28(2):29–62.
Alyas F, James SL, Davies AM, Saifuddin A. The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. Eur Radiol. 2007;17(10):2675–86.
Wootton-Gorges SL. MR imaging of primary bone tumors and tumor-like conditions in children. Magn Reson Imaging Clin N Am. 2009;17(3):469–87.
Hagspiel KD, Kandarpa K, Jolesz FA. Interventional MR imaging. J Vasc Interv Radiol. 1997;8:745–58.
McDannold NJ, Jolesz FA. Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging. 2000;11:191–202.
Hynynen K, Kettenbach J, Kacher DF, et al. Interventional and intraoperative magnetic resonance imaging. Annu Rev Biomed Eng. 2000;2:661–90.
Lu DS, Lee H, Farahani K, et al. Biopsy of hepatic dome lesions: semi-real-time coronal MR guidance technique. AJR Am J Roentgenol. 1997;168:737–9.
Silverman SG, Tuncali K, Morrison PR. MR Imaging-guided percutaneous tumor ablation. Acad Radiol. 2005;12:1100–19.
Morrison PR, Silverman SG, Tuncali K, Tatli S. MRI-guided cryotherapy. J Magn Reson Imaging. 2008;27(2):410–20.
Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226(3):897–905.
Tuncali K, Morrison PR, Tatli S, Silverman SG. MRI-guided percutaneous cryoablation of renal tumors: use of external manual displacement of adjacent bowel loops. Eur J Radiol. 2006;59(2):198–202.
Silverman SG, Jolesz FA, Newman RW, et al. Design and implementation of an interventional MR imaging suite. AJR Am J Roentgenol. 1997;168:1465–71.
Silverman SG, Collick BD, Figueira MR, et al. Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology. 1995;197:175–81.
Wallis F, Gilbert FJ. Magnetic resonance imaging in oncology: an overview. J R Coll Surg Edinb. 1999;44(2):117–25.
Salomonowitz E. MR imaging-guided biopsy and therapeutic intervention in a closed-configuration magnet: single-center series of 361 punctures. AJR Am J Roentgenol. 2001;177:159–63.
Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology. 2010;257(3):624–40.
Fenchel S, Boll DT, Lewin JS. Intraoperative MR imaging. Magn Reson Imaging Clin N Am. 2003;11(3):431–47.
Johnston T, Moser R, Moeller K, Moriarty TM. Intraoperative MRI: safety. Neurosurg Clin N Am. 2009;20(2):147–53.
Jolesz FA, Morrison PR, Koran SJ, et al. Compatible instrumentation for intraoperative MRI: expanding resources. J Magn Reson Imaging. 1998;8:8–11.
Keeler EK, Casey FX, Engels H, et al. Accessory equipment considerations with respect to MRI compatibility. J Magn Reson Imaging. 1998;8:12–8.
Bedrosian I, Schlencker J, Spitz FR, et al. Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann Surg Oncol. 2002;9(5):457–61.
Liberman L, Bracero N, Morris E, Thornton C, Dershaw DD. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol. 2005;185(1):183–93.
Kuhl CK, Morakkabati N, Leutner CC, et al. MR imaging–guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220:31–9.
Perlet C, Heywang-Kobrunner SH, Heinig A, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer. 2006;106:982–90.
Hata N, Jinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology. 2001;220(1):263–8.
Cormack RA, D’Amico AV, Hata N, Silverman S, Weinstein M, Tempany CM. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology. 2000;56(4):663–4.
D’Amico AV, Tempany CM, Cormack R, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol. 2000;164:385–7.
Lichy MP, Anastasiadis AG, Aschoff P, et al. Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels. Urology. 2007;69(6):1208.e5–8.
Buchanan CL, Morris EA, Dorn PL, et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005;12:1045–53.
Eby PR, Lehman C. MRI-guided breast interventions. Semin Ultrasound CT MR. 2006;27:339–50.
Meeuwis C, Peters NH, Mali WP, et al. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet. Eur J Radiol. 2007;62:283–8.
Bloom S, Morrow M. A clinical oncologic perspective on breast magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18(2):277–94.
Philpotts LE. MR intervention: indications, technique, correlation and histologic. Magn Reson Imaging Clin N Am. 2010;18(2):323–32.
Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol. 1994;162(4):865–72.
Haker SJ, Mulkern RV, Roebuck JR, Barnes AS, Dimaio S, Hata N, Tempany CM. Magnetic resonance-guided prostate interventions. Top Magn Reson Imaging. 2005;16(5):355–68.
Zangos S, Herzog C, Eichler K, et al. MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland. Eur Radiol. 2007;17:1118–24.
Barnes AS, Haker SJ, Mulkern RV, et al. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology. 2005;66:1319.
Susil RC, Menard C, Krieger A, et al. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5 T magnetic resonance imaging scanner. J Urol. 2006;175:113–20.
Fennessy FM, Tuncali K, Morrison PR, Tempany CM. MR imaging-guided interventions in the genitourinary tract: an evolving concept. Magn Reson Imaging Clin N Am. 2010;18(1):11–28.
Zhang Q, Chung YC, Lewin JS, Duerk JL. A method for simultaneous RF ablation and MRI. J Magn Reson Imaging. 1998;8(1):110–14.
Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217:657–64.
Silverman SG, Tuncali K, vanSonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy – initial experience in 23 patients. Radiology. 2005;236:716–24.
Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170:1126–30.
Nurko J, Mabry CD, Whitworth P, et al. Interim results from the FibroAdenoma Cryoablation Treatment Registry. Am J Surg. 2005;190:647–51.
Tuncali K, Morrison PR, Winalski CS, et al. MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol. 2007;189:232–9.
Sakuhara Y, Shimizu T, Kodama Y, et al. Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol. 2006;29:552–8.
Cline HE, Schenck JF, Hynynen K, et al. MR-guided focused ultrasound surgery. J Comput Assist Tomogr. 1992;16:956–65.
Cline HE, Hynynen K, Hardy CJ, et al. MR temperature mapping of focused ultrasound surgery. Magn Reson Med. 1994;31:628–36.
Tempany CM, Stewart EA, McDannold N, et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226:897–905.
Mulkern RV, Panych LP, McDannold NJ, et al. Tissue temperature monitoring with multiple gradient-echo imaging sequences. J Magn Reson Imaging. 1998;8:493–502.
Kuroda K, Oshio K, Chung AH, et al. Temperature mapping using the water proton chemical shift: a chemical shift selective phase mapping method. Magn Reson Med. 1997;38:845–51.
Jolesz FA, Hynynen K, McDannold N, et al. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am. 2005;13:545–60.
Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 2001;219:176–85.
Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer. 2005;12:32–8.
Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery – results of different treatment protocols. Radiology. 2007;243:885–93.
Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, Pfeffer RM, Hanannel A, Dogadkin O, Liberman B, Kopelman D. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – preliminary clinical experience. Ann Oncol. 2007;18(1):163–7.
Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M. Palliative treatment of painful bone metastases with MR imaging – guided focused ultrasound. Radiology. 2008;249(1):355–63.
Watkin NA, Morris SB, Rivens IH, et al. High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol. 1997;11:191–6.
Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol. 2006;59:157–62.
McDannold N, Moss M, Killiany R, et al. MRI-guided focused ultrasound surgery in the brain: tests in a primate model. Magn Reson Med. 2003;49:1188–91.
Nag S, Cardenes H, Chang S, Image-Guided Brachytherapy Working Group, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys. 2004;60(4):1160–72.
Cormack RA. Quality assurance issues for computed tomography-, ultrasound-, and magnetic resonance imaging-guided brachytherapy. Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S136–41.
Stokes SH. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys. 2000;47:129–36.
Pfeiffer D, Sutlief S, Feng W, Pierce HM, Kofler J. AAPM Task Group 128: quality assurance tests for prostate brachytherapy ultrasound systems. Med Phys. 2008;35(12):5471–89.
D’amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003;62:1063–7.
Talcott JA, Clark JA, Stark PC, et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol. 2001;166:494–9.
Hurwitz MD, Cormack R, Tempany CM, et al. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side-effect profile in patients with clinically localized prostate cancer. Tech Urol. 2000;6:89–94.
D’Amico AV, Cormack RA, Tempany CM. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med. 2001;344:776–7.
Cormack RA, Kooy H, Tempany CM, et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2000;46:207–14.
D’Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998;42:507–15.
Mislow JM, Golby AJ, Black PM. Origins of intraoperative MRI. Neurosurg Clin N Am. 2009;20(2):137–46.
Black PM, Moriarty T, Alexander 3rd E, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery. 1997;41(4):831–42.
Schwartz RB, Hsu L, Wong TZ, et al. Intraoperative MR imaging guidance for intracranial neurosurgery: experience with the first 200 cases. Radiology. 1999;211(2):477–88.
Pergolizzi Jr RS, Nabavi A, Schwartz RB, et al. Intra-operative MR guidance during trans-sphenoidal pituitary resection: preliminary results. J Magn Reson Imaging. 2001;13(1):136–41.
Bootz F, Schulz T, Weber A, Scheffler B, Keiner S. The use of open MRI in otorhinolaryngology: initial experience. Comput Aided Surg. 2001;6(5):297–304.
Schulz T, Schneider JP, Bootz F, et al. Transnasal and transsphenoidal MRI-guided biopsies of petroclival tumors. J Magn Reson Imaging. 2001;13(1):3–11.
Dort JC, Sutherland GR. Intraoperative magnetic resonance imaging for skull base surgery. Laryngoscope. 2001;111(9):1570–5.
Fried MP, Topulos G, Hsu L, et al. Endoscopic sinus surgery with magnetic resonance imaging guidance: initial patient experience. Otolaryngol Head Neck Surg. 1998;119(4):374–80.
Gould SW, Lamb G, Lomax D, Gedroyc W, Darzi A. Interventional MR-guided excisional biopsy of breast lesions. J Magn Reson Imaging. 1998;8(1):26–30.
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–16.
Klaeser B, Mueller MD, Schmid RA, Guevara C, Krause T, Wiskirchen J. PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experience. Eur Radiol. 2009;19:1780–5.
Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 2004;240(6):1027–34.
Tatli S, Gerbaudo VH, Mamede M, Tuncali K, Shyn PB, Silverman SG. Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images. Radiology. 2010;256(1):305–11.
Soher BJ, Dale BM, Merkle EM. A review of MR physics: 3 T versus 1.5 T. Magn Reson Imaging Clin N Am. 2007;15(3):277–90.
DeLano MC, Fisher C. 3 T MR imaging of the brain. Magn Reson Imaging Clin N Am. 2006;14(1):77–88.
Nagae-Poetscher LM, Jiang H, Wakana S, Golay X, van Zijl PC, Mori S. High-resolution diffusion tensor imaging of the brain stem at 3 T. AJNR Am J Neuroradiol. 2004;25(8):1325–30.
Ramnath RR. 3 T MR imaging of the musculoskeletal system (Part II): clinical applications. Magn Reson Imaging Clin N Am. 2006;14(1):41–62.
Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rofsky NM. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol. 2004;11(8):857–62.
Bammer R, Schoenberg SO. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging. 2004;15(3):129–58.
Glockner JF, Hu HH, Stanley DW, Angelos L, King K. Parallel MR imaging: a user’s guide. Radiographics. 2005;25(5):1279–97.
Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16(4):407–22.
Kwee TC, Takahara T, Klomp DW, Luijten PR. Cancer imaging: novel concepts in clinical magnetic resonance imaging. J Intern Med. 2010;268(2):120–32.
Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging; a signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101–10.
Bloch BN, Furman-Haran E, Helbich TH, et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging–initial results. Radiology. 2007;245(1):176–85.
Thomassin-Naggara I, Daraï E, Cuenod CA, Rouzier R, Callard P, Bazot M. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging. 2008;28(1):111–20.
Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217(2):331–45.
Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol. 2001;22:1081–8.
Stadnik TW, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol. 2001;22:969–76.
Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology. 2006;239(3):632–49.
Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging. 2007;25(4):848–58.
Low RN. Diffusion-weighted MR, imaging for whole body metastatic disease and lymphadenopathy. Magn Reson Imaging Clin N Am. 2009;17(2):245–61.
Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22(4):275–82.
Komori T, Narabayashi I, Matsumura K, et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21(4):209–15.
Harisinghani MG, Saini S, Weissleder R, et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol. 1999;172(5):1347–51.
Schick F. Whole-body MRI, at high field: technical limits and clinical potential. Eur Radiol. 2005;15(5):946–59.
Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology. 2004;233(1):139–48.
Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. J Am Med Assoc. 2003;290(24):3199–206.
Raylman RR, Majewski S, Velan SS, et al. Simultaneous acquisition of magnetic resonance spectroscopy (MRS) data and positron emission tomography (PET) images with a prototype MR-compatible, small animal PET imager. J Magn Reson. 2007;186(2):305–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Tatli, S., Silverman, S.G. (2013). Imaging of Interventional Therapies in Oncology: Magnetic Resonance Imaging. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0751-6_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0750-9
Online ISBN: 978-1-4419-0751-6
eBook Packages: MedicineReference Module Medicine